Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets

COVID 19 pandemic and mass vaccination campaigns have revealed the situation of the most vulnerable patients. In this work, we focused our attention to patients who have Multiple Sclerosis (MS), particularly in treatment with cladribine tablets, trying to understand if and when it is possible to adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Moiola, Lucia, Riva, Agostino, Nicoletti, Ferdinando, Uccelli, Antonio, Salvetti, Marco, Battistini, Luca, Furlan, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886810/
https://www.ncbi.nlm.nih.gov/pubmed/34923946
http://dx.doi.org/10.2174/1570159X20666211217160451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886810/
https://www.ncbi.nlm.nih.gov/pubmed/34923946
http://dx.doi.org/10.2174/1570159X20666211217160451

Ejemplares similares